Luke Fostvedt

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study

Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein et al. · Blood Advances · 2017 · 130 citations · Full text

Improving critical thinking growth for disadvantaged groups within elementary school science: A randomized controlled trial using the Science Writing Heuristic approach

Brian Hand, Mack Shelley, Marcia Laugerman et al. · Science Education · 2018 · 69 citations

Inquiry-based Learning, Science Education, Educational Psychology +19

Why do simple algorithms for triangle enumeration work in the real world?

Jonathan W. Berry, Luke Fostvedt, Daniel J. Nordman et al. · 2014 · 44 citations

Engineering, Planar Graph, Computational Complexity +18

Pharmacokinetic/Pharmacodynamic Modeling to Support the Re‐approval of Gemtuzumab Ozogamicin

Luke Fostvedt, Jennifer Hibma, Joanna C. Masters et al. · Clinical Pharmacology & Therapeutics · 2019 · 32 citations · Full text

Metabolism, Excretion, and Pharmacokinetics of Lorlatinib (PF‐06463922) and Evaluation of the Impact of Radiolabel Position and Other Factors on Comparability of Data Across 2 ADME Studies

Daria Stypinski, Luke Fostvedt, Justine L. Lam et al. · The Journal of Clinical Pharmacology · 2020 · 22 citations